We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type |
---|---|---|---|
R1 RCM Inc | NASDAQ:RCM | NASDAQ | Common Stock |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
-0.019 | -0.15% | 12.331 | 12.33 | 12.34 | 12.495 | 12.05 | 12.23 | 719,919 | 20:26:06 |
|
Delaware
|
|
02-0698101
|
(State or Other Jurisdiction of
Incorporation or Organization)
|
|
(I.R.S. Employer Identification Number)
|
401 N Michigan Avenue, Suite 2700 Chicago, Illinois
|
|
60611
|
(Address of Principal Executive Offices)
|
|
(Zip Code)
|
Large accelerated filer
o
|
Accelerated filer
þ
|
Non-accelerated filer
o
|
Smaller Reporting Company
o
|
|
(Do not check if a smaller reporting company)
|
|
Title of Securities to be Registered
|
Amount to be Registered (1)
|
Proposed Maximum Offering Price Per Share
|
Proposed Maximum Aggregate Offering Price
|
Amount of Registration Fee
|
Common Stock, $0.01 par value per share
|
17,000,000 shares (2)
|
$2.37 (3)
|
$40,290,000 (3)
|
$4,670 (4)
|
(2)
|
This Registration Statement on Form S-8 covers 17,000,000 additional shares of common stock, par value $0.01 per share, of Accretive Health, Inc. available for issuance pursuant to awards under the registrant’s Second Amended and Restated 2010 Stock Incentive Plan (the “Plan”).
|
(3)
|
Estimated solely for the purpose of calculating the registration fee pursuant to Rules 457(c) and 457(h) of the Securities Act of 1933, as amended, and based upon the average of the high and low prices of the registrant’s Common Stock as reported on the OTC Markets Group, Inc. on December 12, 2016.
|
(4)
|
Pursuant to General Instruction E to Form S-8, a filing fee is only being paid with respect to the registration of additional securities for the Plan. Registration Statements on Form S-8 have been filed previously on November 19, 2010 (File No. 333-170718) and August 20, 2015 (File No. 333-206482) covering an aggregate of 29,374,756 shares of common stock reserved for issuance pursuant to awards under the Plan.
|
Signature
|
|
Title
|
|
Date
|
|
|
|
||
/s/ Joseph Flanagan
Joseph Flanagan
|
|
President, Chief Executive Officer and Chief Operating Officer
(Principal Executive Officer)
|
|
December 14, 2016
|
|
|
|
||
/s/ Christopher Ricaurte
Christopher Ricaurte
|
|
Chief Financial Officer and Treasurer
(Principal Financial Officer)
|
|
December 14, 2016
|
|
|
|
||
/s/ Richard Evans
Richard Evans
|
|
Principal Accounting Officer
|
|
December 14, 2016
|
|
|
|
|
|
/s/ Steven J. Shulman
Steven J. Shulman
|
|
Chairman of the Board
|
|
December 14, 2016
|
|
|
|
||
/s/ Charles J. Ditkoff
Charles J. Ditkoff
|
|
Director
|
|
December 13, 2016
|
|
|
|
||
/s/ John B. Henneman III
John B. Henneman III
|
|
Director
|
|
December 14, 2016
|
|
|
|
||
/s/ Joseph R. Impicciche
Joseph R. Impicciche
|
|
Director
|
|
December 14, 2016
|
|
|
|
|
|
/s/ Alex J. Mandl
Alex J. Mandl
|
|
Director
|
|
December 14, 2016
|
|
|
|
|
|
/s/ Neal Moszkowski
Neal Moszkowski
|
|
Director
|
|
December 14, 2016
|
|
|
|
||
/s/ Ian Sacks
Ian Sacks
|
|
Director
|
|
December 14, 2016
|
|
|
|
||
/s/ Anthony J. Speranzo
Anthony J. Speranzo
|
|
Director
|
|
December 14, 2016
|
Number
|
Description
|
5.1
|
Opinion of Kirkland & Ellis LLP, counsel to the Registrant
|
10.1*
|
Second Amended and Restated 2010 Stock Incentive Plan
|
23.1
|
Consent of Kirkland & Ellis LLP
(included in Exhibit 5.1)
|
23.2
|
Consent of Ernst & Young LLP
|
24.1
|
Power of attorney (included on the signature pages of this registration statement)
|
|
|
*
|
Previously filed as Exhibit 10.1 to the Registrant’s Current Report on Form 8-K (File No. 001-34746) filed with the Securities and Exchange Commission on December 12, 2016 and incorporated herein by reference.
|
1 Year R1 RCM Chart |
1 Month R1 RCM Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions